On Monday, the FDA approved iRhythm Technologies, Inc.’s (NASDAQ:IRTC) 510(k) submission related to prior design changes to the Zio AT device via letter to file. Zio AT remains commercially available ...

Remote biometric monitoring technology company Biotricity recently announced securing National Institutes of Health funding from the National Heart, Blood and Lung Institute with plans to launch a ...

iRhythm Technologies, a digital healthcare company specializing in cardiac telemetry products, received a warning letter from the FDA on May 25 detailing multiple issues with its Zio AT device. The ...

A suite of sensors, such as 1-lead ECG, SPO2, temperature, BP, and weight scale, that can be used by the patients at home and transmit their vital signs and other measurements to the cloud in ...

Future Cardia, a medical device company, announced an expanded collaboration with remote cardiac monitoring company, Artella Solutions. Future Cardia is developing an implantable cardiac monitoring ...

The company's products, HeartBeam AIMI and HeartBeam AIMIGo, are being developed with the aim of providing accurate diagnostic tools for heart attack detection anytime and anywhere. The core ...

Experts discuss how choosing the right cardiac rhythm monitor involves balancing symptom frequency, patient risk, and device capabilities to ensure efficient, cost-effective, and patient-centered ...

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation for patients with hypertension, Medtronic announced. The FDA said Philips ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, a medical technology company delivering clinical-grade ECG interpretation software, announced today that its flagship product, the AccurECG™ Analysis System ...